Lung Cancer Survival in Patients With Autoimmune Disease | Zendy

Saya Jacob | Zendy; Kian J. Rahbari | Zendy; Kyle Tegtmeyer | Zendy; Jeffrey Zhao | Zendy; Steven Tran | Zendy; Irene Helenowski | Zendy; Hui Zhang | Zendy; Theresa L. Walunas | Zendy; John Varga | Zendy; Jane E. Dematte | Zendy; Victoria Villaflor | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lung Cancer Survival in Patients With Autoimmune Disease

Author(s) -

Saya Jacob,

Kian J. Rahbari,

Kyle Tegtmeyer,

Jeffrey Zhao,

Steven Tran,

Irene Helenowski,

Hui Zhang,

Theresa L. Walunas,

John Varga,

Jane E. Dematte,

Victoria Villaflor

Publication year - 2020

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2020.29917

Subject(s) - medicine , lung cancer , cancer , oncology , adenocarcinoma , autoimmune disease , disease , immunology

Key Points Question Is there an association between autoimmune disease and lung cancer survival? Findings This cohort study of 349 patients compared lung cancer survival in those with autoimmune disease with that of patients without it and observed no difference in overall survival, even when broken down by locoregional and distant stage. No one subtype of autoimmune disease was associated with worse survival compared with that of the control cohort, including survival of patients with underlying interstitial lung disease. Meaning In this study, no significant difference in lung survival for patients with autoimmune disease compared with controls was observed, despite the fact that fewer patients in this group received standard-of-care lung cancer treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research